Treatment of larval toxocarosis in mice with fenbendazole entrapped in neutral and negativêly charged liposomes

Helminthologia

Volumn 37, Issue 3, 2000, Pages 119-125

  Velebny S ^a   Hrckova G ^a   Tomasovicova O ^a   Dubinsky P ^a  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

Author keywords

Efficacy; Fenbendazole; Glucan; Liposomes; Mouse; Size distribution of liposomes; Toxocara canis

Indexed keywords

EID: 0346112766     PISSN: 04406605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Allen, T. M. (1988): Interaction of liposomes and other drug carriers with the mononuclear phagocyte system. In Gregoriadis, G. (Ed.): Liposomes as Drug Carriers. Recent Trends and Progress. John Wiley & Sons Ltd, Chichester, New York, Brisbane, Toronto, Singapore
2. Baeder, C., Bähr, H., Christ, O., Düwel, D., Kellner, H.M., Kirsch, R., Loewe, H., Schultes, E., Schütz, E., Westen, H. (1974): Fenbedazole: A new, highly effective anthelmintic. Experientia, 30: 753-754
3. Bangham, A. D., Standish, M. M., Watkins, J.C. (1965): Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Molec. Biol., 13: 238-247
4. Bergquist, L., Strand, S. E., Perssen, B.R.R. (1983): Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin. Nucl. Med., 13: 9-19
5. Bogan, J.A., Marriner, S. E. (1984): Pharmacodynamic and toxicological aspects of albendazole in man and animals. In Firth, M. (Ed.): Albendazole in Helminthiasis. University Press, Oxford.
6. Borošková Z., Šoltýs J., Havasiová-Reiterová, K., Dubinský, P., Tomašovičová, O., Turčeková, L'. (1993): Response of lymphocytes to mitogens and antibody level in mice with experimental larval toxocarosis. Helminthologia, 30: 115-118
7. Borošková, Z., Dvorožňáková, E., Dubinský, P., Velebný, S., Tomašovičova, O., Machnicka, B. (1998): Effect of free and liposomized albendazole on the immune responses in healthy and Toxocara canis-infected mice. Vet. Med.-Czech, 43: 293-300
8. Cawley, S., Ormrod, D.J., Miller, T.E. (1987): Immunopotentiation in infections disease: Effect of glucan and lentinan on host defences and experimental infections. Int. J. Immunother., 3: 159-170
9. Daleke, D. L., Hong, K., Papahadjopoulos, D. (1990): Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim. Biophys. Acta, 1024: 352-366
10. Doenhoff, M.J., Sabah, A. A., Fletcher, C., Webbe, G., Bain, J. (1987): Evidence for an immuno-dependent action of praziquantel on S. mansoni in mice. Trans. Roy. Soc. Trop. Med. Hyg., 81: 947-951
11. Düwel, D. (1976): Panacur-die Entwicklung eines neuen Breitband-Anthelmintikums. Die Blauen Hefte, 55: 89-203
12. Eppstein, D.A., Felgner, P. L. (1988): Applications of liposome formulations for antimicrobial/antiviral therapy. In Gregoriadis, G. (Ed.) Liposomes as Drug Carriers. Recent Trends and Progress. John Wiley & Sons Ltd, Chichester, New York, Brisbane, Toronto, Singapore
13. Fielding, R.M. (1991): Liposomal drug delivery. Advantages and limitations from clinical, pharmacokinetic and therapeutic perspective. Clin. Pharmacokinet., 21: 135-164
14. Fok, E., Kassai, T. (1998): Toxocara canis infection in the paratenic host: A study on the chemosusceptibility of the somatic larvae in mice. Vet. Parasitol., 74: 243-259
15. Gregoriadis, G. (1976): The carrier potential of liposomes in biology and medicine. New Engl. J. Med., 295: 704-710
16. Juliano, R. L., Stamp, D. (1975): Effects of particle size and charge on the clearance of liposomes and liposome-encapsulated drugs. Biochem. Biophys. Res. Comm., 63: 651-658
17. Kadir, F., Eling, W. M. C., Crommelin, D. J. A., Zuidema, J. (1991): Influence of infection volume on the release kinetics of liposomal chloroquine administered subcuntaneously or intramuscularly to mice. J. Contr. Rel., 17: 277-284
18. Katare, O. P., Vyas, S. P. Dixit, V.K. (1991): Proliposomes of indomethacin for oral administration. J. Microencaps., 8: 1-7
19. Kawada, J., Tanaka, M., Nozaki, Y. (1981): No reduction of blood glucose in diabetic rats after oral administration of insulin liposomes prepared under acidic conditions. Endocrinol. Japn., 28: 235-238
20. Kirby, C., Gregoriadis, G. (1980): The effect of cholesterol content of small unilamellar liposomes on the fate of their lipid components in vivo. Lite Sci., 27: 2223-2230
21. Magnaval, J. F. (1995): Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology, 110: 529-534
22. New, R. R. C. (1990): Liposomes: A Practical Approach. IRL Press, Oxford Univeristy Press, Oxford.
23. New, R. R. C., Wen, H., Craig, P.S., Zou, P. F., Merdan, M., Wang, J. H., Wang, Y. H., Zhang, J. H. (1994): Efficacy of albendazole administered orally is improved by encapsulation in liposomes. J. Contr. Release, 28: 350-351
24. Patel, H. M. (1988): Fate of liposomes in the lymphatics. In Gregoriadis, G. (Ed.): Liposomes as Drug Carriers. Recent Trends and Progress. John Wiley & Sons Ltd, Chichester, New York, Brisbane, Toronto, Singapore Reference Manual for the Coulter Counter Model D (Industrial).
25. Saba, T. M. (1970): Physiology and pathophysiology of the reticulo-endothelial system. Arch. Intern. Med. 126: 1031-1052
26. Sabah, A. A., Fletcher, C., Webbe, G., Doenhoff, M. J. (1985): Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell deprivated mice. Exp. Parasitol., 60: 348-354
27. Segal, A.W., Gregoriadis, G., Black, C. D. V. (1975): Liposomes as vehicles for the local release of drugs. Clin. Sci. Mol. Med., 49: 99-106
28. Senior, J. (1987): Fate and behaviour of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Syst., 3: 123-193
29. Senior, J., Gregoriadis, G. (1982): Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components. Life Sci., 30: 2123-2136
30. Stoye, M., Vorbohle, H. J. (1985): Zur Wirkung von Fenbendazol auf ruhende somatische Larven von Toxocara canis Werner 1782 (Anisakidae) in den graviden Hündin. Zbl. Vet. Med., B32: 637-651
31. Terasaki, T., Tsuji, A. (1994): Drug delivery to the brain utilizing blood-brain barrier transport systems. J. Contr. Release, 29: 163-169
32. Terry, R., Hudson, K. (1982): Immunodepression in parasitic infections. Fortschritte der Zoologie, Band 27. In Zbl. Bakteriol. Immune Reactions. Suppl. 12. Gustav Fischer Verlag. Stuttgart and New York
33. 111in-labelled bleomycin after subcutaneous injection into rats. Biochim. Biophys. Acta, 760: 119-125
34. Velebný, S., Tomašovičová, O., Hrčková, G., Dubinský, P. (1997): Toxocara canis in mice: Are liposomes and immunomodulator able to enhance the larvicidal effect of the anthelmintic? Helminthologia, 34: 147-153
35. Weiner, N., Chiang, Ch.-M. (1988): Gastrointestinal uptake of liposomes. In Gregoriadis, G. (Ed.) Liposomes as Drug Carriers. Recent Trends and Progress. John Wiley & Sons Ltd, Chichester, New York, Brisbane, Toronto, Singapore
36. Whistler, R. L., Bushway, A. A., Sing, P. P. (1976): Monocytotoxic antitumour polysaccharides. Chem. Biochem., 31: 235-241
37. Woodley, J.F. (1986): Liposomes for oral administration of drug. CRC Crit. Rev. Ther. Drug. Carrier Syst., 2: 1-18
38. Zumbuhl, O., Waldrogel, S., Asanger, M., Roos, K., Velvart, M. et al. (1987): Liposomes as drug delivery systems. In Müller (Ed.): Controlled drug delivery. Wissenschaftliche Verlagsgesellschaft, Stutgart